The National Comprehensive Cancer Network (NCCN)-;an alliance of leading cancer centers focusing on maintaining evidence-based expert consensus driven guidelines for care-;announces the publication of the expanded NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate.
LJI scientists discover a potential new target for treating Parkinson’s disease
Scientists at La Jolla Institute for Immunology (LJI) have found a potential new target for treating Parkinson’s disease.